Anthem Biosciences Limited IPO
DRHP 31 Dec 2024 · listed 21 Jul 2025
Follow this IPOuse-of-proceeds reports, on Telegram
- Issue price
- ₹570.00
- band ₹540.00 to ₹570.00
- Subscription window
- 14 Jul to 16 Jul
- 2025
- Listing
- 21 Jul 2025
- NSE
- Subscribed
- 27.0x
- retail 2.3x
About the Anthem Biosciences IPO
Anthem Biosciences Limited raised money through a mainboard IPO on NSE and BSE.
Bidding ran Mon 14 Jul to Wed 16 Jul, at an issue price of ₹570 a share. The shares listed on 21 Jul 2025.
The book-running lead managers are JM Financial Limited, Citigroup Global Markets India Private Limited and J.P. Morgan India Private Limited. The registrar, which handles allotment, is KFin Technologies Limited.
The issue was subscribed 27.01 times overall, with the retail portion at 2.26 times, as the exchange's bid book showed.
The draft offer document was filed on 31 Dec 2024.
newboard writes its studies from the offer document before an issue lists, and this one listed without one. The figures on this page are the exchange's and the offer document's, each with its source.
Anthem Biosciences IPO: questions answered
When was the Anthem Biosciences IPO open, and what were the price band and lot size?
Bidding ran Mon 14 Jul to Wed 16 Jul. The issue price is ₹570 a share.
When did the Anthem Biosciences IPO list?
The shares listed on 21 Jul 2025 on NSE and BSE.
How do I check the Anthem Biosciences IPO allotment status?
Allotment is finalised by the registrar, KFin Technologies Limited, usually the working day after the issue closes. Check it on the registrar's website or on BSE and NSE with a PAN, application number or DP ID. Shares not allotted have their blocked amount released by the refund date.
The Anthem Biosciences IPO allotment status page, with the direct links
Who are the registrar and lead managers of the Anthem Biosciences IPO?
The book-running lead managers are JM Financial Limited, Citigroup Global Markets India Private Limited and J.P. Morgan India Private Limited. The registrar, which handles applications and allotment, is KFin Technologies Limited.
How many times was the Anthem Biosciences IPO subscribed?
27.01 times overall, as the exchange's bid book last showed: qualified institutions 76.36 times, non-institutional investors 11.9 times and retail 2.26 times.
What is the Anthem Biosciences IPO GMP?
newboard does not publish a grey-market premium. Grey-market deals happen outside the stock exchanges, are not regulated, and leave no public record of who traded at what price. What is on record is the offer document, read on this page, and the exchanges' bid book.
Anthem Biosciences IPO: the next step, on Telegram
A message when there is news on each use-of-proceeds report the company files. Free, no account, leave in one tap. Send /stop to end it.
Not on this page yet: an offer-document study, the peer table the issuer printed. Each is added when the pipeline extracts it from the offer document.
The figures on this page are the company's own, taken from its filings with the exchanges and SEBI, and every number links to the document and page it came from. They are reproduced as stated, not verified independently, and they are not forecasts by newboard.in. Nothing here is investment advice, a research report or a recommendation. newboard.in is not a SEBI-registered research analyst or investment adviser.